Keyword Connections

maximum tolerated dose

Journals

3

1 cancer chemotherapy and pharmacology

2 the lancet oncology

3 pancreas

Research Groups

0

No Research Group Connected

Bibliographies

3

1 Safety and pharmacokinetics of cabazitaxel in patients with hepatic impairment: a phase I dose-escalation study.

2 Erlotinib, cabozantinib, or erlotinib plus cabozantinib as second-line or third-line treatment of patients with EGFR wild-type advanced non-small-cell lung cancer (ECOG-ACRIN 1512): a randomised, controlled, open-label, multicentre, phase 2 trial.

3 Association Between Somatostatin Receptor Expression and Clinical Outcomes in Neuroendocrine Tumors.